Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford

NCT05416554 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non Hodgkin Lymphoma

Interventions

BEHAVIORAL: Neuropsychological testing

Sponsor

Stanford University